Radioiodinated methylene blue - A promising agent for melanoma scintigraphy: Labelling, stability and in vitro uptake by melanoma cells

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3691-3696

  Sobal, Grazyna ^a   Rodrigues, Margarida ^a   Sinzinger, Helmut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

518A2; Melanoma imaging; Radioiodinated methylene blue; SK MEL 28

Indexed keywords

ACETONITRILE; IODINE 131; METHYLENE BLUE; METHYLENE BLUE I 131; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE I 131; SOLVENT; TRACER; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG; WATER;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL STRAIN; CONTROLLED STUDY; DRUG STABILITY; DRUG UPTAKE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; QUALITY CONTROL; RADIODIAGNOSIS; SCINTIGRAPHY; STRAIN DIFFERENCE; TEMPERATURE; TIME; WILD TYPE;

CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MELANOMA; METHYLENE BLUE; RADIOPHARMACEUTICALS; SODIUM IODIDE;

EID: 58149156692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Potts AM: The reaction of uveal pigment in vitro with poly cyclic compounds: Invest Ophthalmol 3: 405-416, 1964.
2. Link E, Costa DC, Lui D, Ell PJ, Blower PJ and Spittle MF: Targeting disseminated melanoma with radiolabelled methylene blue. Comparative biodistribution studies in men and animals. Acta Oncologica 35: 331-341, 1996.
3. Blower PJ, Clark K and Link EM: Radioiodinated methylene blue for melanoma targeting: chemical characterisation and tumor selectivity of labelled components. Nuc Med Biol 24: 305-310, 1997.
4. Link EM, Blower PJ, Costa DC, Ell PJ, Lane D and Spittle MF: Diagnostic potential of radioiodinated methylene blue for early melanoma metastasis. Lancet 343: 753-760, 1996.
5. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of micrometastases. Cancer Res 50: 2963-2967, 1990.
6. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of cutaneous tumors and lymph node metastases. Cancer Res 52: 4385-4390, 1992.
7. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumors. Eur J Cancer 32A: 1240-1247, 1996.
8. 211At-methylene blue for targeted radiotherapy of disseminated melanoma. Pigment Cell Res 7: 358-362, 1994.
9. 123I-labelled methylene blue and toluidine blue: potential new agents for parathyroid scintigraphy. Nuc Med Comm 11: 413-420, 1990.
10. Czerniak P and Boruchowsky S: Labelling of toluidine blue with radioactive iodine. J Labelled Comp 7: 541-543, 1970.
11. Soenarto S: Labelling of toluidine blue with radioiodine (131I). Majalah Batan 14: 13, 1981.
12. Dadachova E and Casadevall A: Melanin as a potential target for radionuclide therapy of metastatic melanoma. Future Oncol 1: 541-549, 2005.
13. Dadachova E and Casadevall A: Renaissance of targeting molecules for melanoma. Cancer Biother Radiopharm 21: 545-552, 2006.
14. 131I- methylene blue: preclinical and clinical experience. Hybridoma 18: 77-82, 1999.
15. Packer S, Redvanly C, Lambrecht RM, Wolf AP and Atkins HL: Quinoline analog labelled with iodine 123 in melanoma detection. Arch Ophthalmol 93: 504-508, 1975.
16. Boni R, Steinert H and Huch-Boni R: Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients. Br J Dermatol 137: 96-100, 1997.
17. Kirkwood JM, Meyrs JE and Vlock DR: Tomographic gallium-67 citrate scanning: usefull new surveillance for metastatic melanoma. Ann Intern Med 97: 694-999, 1982.
18. Alonso O, Martinez M and Lago G: Scintigraphic detection of invasive cutaneous malignant melanoma with Tc-99m-MIBI. Clin Nucl Med 21: 557-559, 1996.
19. Meghdadi S, Karanikas G and Schlagbauer-Wadl H: Technetium-99m- tetrofosmin a new agent for melanoma imaging? Anticancer Res 18: 2759-2762, 1998.
20. Grittes LS, Francis IR, Zasadny KR and Wahl RL: Initial assessment of positron emission tomography using 2-flourine-18-flouro-2-desoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 34: 1420-1427, 1993.
21. Miao Y, Hylarides M, Fisher DR, Shelton T, Moore H, Wester DW, Fritzberg AR, Winkelmann CT, Hoffman T and Quinn TP. Melanoma therapy via peptide-targeted {alpha}-radiation. Clin Cancer Res 11: 5616-21, 2005.
22. Dadachova E, Moadel T, Schweitzer AD, Bryan RA, Zhang T, Mints L, Revskaya E, Huang X, Ortiz G, Nosanchuk JS, Nosanchuk JD and Casadevall A: Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. Cancer Biother Radiopharm 21: 117-129, 2006.
23. Howell RC, Revskaya E, Pazo V, Nosanchuk JD, Casadevall A and Dadachova E: Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma. Bioconjug Chem 18: 1739-1848, 2007.
24. Dadachova E, Moadel T, Schweitzer AD, Bryan RA, Zhang T, Mints L, Revskaya E, Huang X, Ortiz G, Nosanchuk JS, Nosanchuk JD and Casadevall A: Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. Cancer Biother Radiopharm 21: 117-129, 2006.
25. Engelstad BL, Spitler LE, Del Rio MJ and Rosendorf LL: Phase 1 immunolymphoscintigraphy with In-111-labelled antimelanoma monoclonal antibodies. Radiology 161: 419-422, 1986.
26. 188Re against experimental human metastatic melanoma in nude mice. Cancer Biol Ther 7: (Epub ahead of print), 2008.
27. 188Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations. Melanoma Res 17: 291-303, 2007.
28. Dadachova E, Nosanchuk JD, Shi L, Schweitzer AD, Frenkel A, Nosanchuk JS and Casadevall A: Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin. Proc Natl Acad Sci USA 101: 14865-14870, 2004.
29. Vieira MR, Rodrigues M and Nogueira A: Imaging malignant melanoma with technetium-99m labelled monoclonal antibodies. Revista de Oncologia 3: 55-57, 1992.
30. Bagutti C, Stolz B, Albert R, Bruns C, Pless J and Eberle AN: (In-111-DTPA)-labelled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo. Int J Cancer 58: 749-755, 1994.
31. Brandau W, Kirchner B, Bartenstein P, Sciuk J, Kamanabrou D and Schober O: N-(2-diethylaminoethyl)-4-[I 123]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results. Eur J Nuc Med 20: 238-243, 1993.
32. Link EM, Blower PJ and Costa DC: Early detection of melanoma metastases with radioiodinated methylene blue. Eur J Nucl Med 25: 1322-1329, 1998.
33. Dadachova E and Casadevall A: Melanin as a potential target for radionuclide therapy of metastatic melanoma. Future Oncol 1: 541-549, 2005.